Survival after Abiraterone resistance will not necessarily be affected.
Abiraterone is a commonly used drug in the clinic for the treatment of advanced prostate cancer. Whether or not a patient’s survival will be affected once drug resistance occurs needs to be analyzed according to the specific situation.
If the patient can find other drugs to replace abiraterone to play the proper role, then it is possible that the patient’s survival will not be affected; if the patient can not find other drugs to replace abiraterone, it is possible that the survival period will be shortened.
Adverse reactions to abiraterone include hypertension, hypokalemia, and fluid retention, and it is contraindicated for those with hypersensitivity reactions to the active ingredient or excipients of abiraterone.
In addition, the taking of abiraterone has certain risks, patients need to get the guidance of a specialist, do not blindly take the drug on their own, so as to avoid delaying the condition.